Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Friday 14 August →